Improved Eating Behaviour and Nutrient Intake in Noncompliant Patients with Phenylketonuria after Reintroducing a Protein Substitute: Observations from a Multicentre Study.
PKU
compliance
eating behaviour
micronutrient
mood
noncompliance
nutrient intake
nutritional status
phenylketonuria
Journal
Nutrients
ISSN: 2072-6643
Titre abrégé: Nutrients
Pays: Switzerland
ID NLM: 101521595
Informations de publication
Date de publication:
30 Aug 2019
30 Aug 2019
Historique:
received:
26
07
2019
revised:
21
08
2019
accepted:
28
08
2019
entrez:
5
9
2019
pubmed:
5
9
2019
medline:
14
2
2020
Statut:
epublish
Résumé
Noncompliance is widespread in adults with PKU and is associated with adverse metabolic, nutritional and cognitive abnormalities. Returning to the PKU diet is important for this at-risk population, yet for many this is challenging to achieve. Strategies that ease the return to the PKU diet, while offering nutritional and cognitive advantages, are needed. Twelve PKU adults (33.7 ± 2.6 years), who had been noncompliant for 4.5 years (range: 1 to 11 years), took 33 g of a low-volume, nutrient-enriched, protein substitute daily for 28 days. Outcomes of eating behaviour, nutrient intake and mood were assessed at entry (baseline, days 1-3) and after the intervention period (days 29-31). At baseline, intakes of natural protein and estimated phenylalanine were high (66.4 g and 3318.5 mg, respectively) and intakes of calcium, magnesium, iron, zinc, iodine and vitamin D were below country-specific recommendations. With use of the experimental protein substitute, natural protein and estimated phenylalanine intake declined (
Identifiants
pubmed: 31480383
pii: nu11092035
doi: 10.3390/nu11092035
pmc: PMC6770397
pii:
doi:
Substances chimiques
Dietary Proteins
0
Phenylalanine
47E5O17Y3R
Types de publication
Journal Article
Multicenter Study
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Nutricia Ltd
ID : n/a
Déclaration de conflit d'intérêts
Employees of Nutricia Ltd.: B.G., G.H. and R.S. Have received educational grants from Nutricia Ltd. for conference attendance: S.A. (Sarah Adam), C.N., S.A. (Sandra Adams), C.D. Have received honorarium from Nutricia Ltd. for conference presentation: S.A. (Sandra Adams) and L.R. Have provided scientific advice and expertise for Nutricia Metabolic Health Professional Advisory Board: Y.R., S.A. (Sarah Adam), L.R., C.D. S.F., F.J., C.D., and A.C. declare no competing interests.
Références
Mol Genet Metab Rep. 2018 Jul 11;16:39-45
pubmed: 30069431
J Inherit Metab Dis. 2000 Jun;23(4):313-6
pubmed: 10896282
Mol Genet Metab. 2001 Mar;72(3):185-98
pubmed: 11243724
Lancet. 2002 Jul 6;360(9326):55-7
pubmed: 12114043
Mol Genet Metab Rep. 2015 Dec 29;6:8-12
pubmed: 27014571
Eur J Pediatr. 2015 Jan;174(1):119-27
pubmed: 25480112
Mol Genet Metab. 2017 Mar;120(3):190-197
pubmed: 28162992
Mol Genet Metab. 2010;99 Suppl 1:S86-9
pubmed: 20123477
Mol Genet Metab. 2011 Feb;102(2):210-3
pubmed: 21035369
Eur J Clin Nutr. 2014 Jan;68(1):119-24
pubmed: 24253763
Mol Genet Metab Rep. 2018 Oct 18;17:57-63
pubmed: 30364670
Ann Nestle Eng. 2010 Jun;68(2):58-69
pubmed: 22475869
J Inherit Metab Dis. 2008 Dec;31 Suppl 2:S415-8
pubmed: 18956249
Mol Genet Metab Rep. 2017 Dec 27;14:80-82
pubmed: 29326880
J Inherit Metab Dis. 2004;27(3):363-71
pubmed: 15190194
J Inherit Metab Dis. 2010 Dec;33(6):665-70
pubmed: 20373144
J Inherit Metab Dis. 2002 Feb;25(1):56-64
pubmed: 11999981
Hum Mutat. 2007 Sep;28(9):831-45
pubmed: 17443661
Lancet Diabetes Endocrinol. 2017 Sep;5(9):743-756
pubmed: 28082082
Rep Health Soc Subj (Lond). 1991;41:1-210
pubmed: 1961974
Genet Med. 2011 Aug;13(8):697-707
pubmed: 21555948
JIMD Rep. 2012;3:131-9
pubmed: 23430885
JIMD Rep. 2014;13:149-58
pubmed: 24222493
Monogr Soc Res Child Dev. 1997;62(4):i-v, 1-208
pubmed: 9421921
J Inherit Metab Dis. 2011 Feb;34(1):165-71
pubmed: 21153445
Lancet. 2010 Oct 23;376(9750):1417-27
pubmed: 20971365
Arch Dis Child. 2007 Mar;92(3):213-8
pubmed: 17068073
Neuropsychology. 2017 Mar;31(3):242-254
pubmed: 28240926
Int J Androl. 1987 Apr;10(2):435-40
pubmed: 3610354
Ann Nutr Metab. 2017;71(3-4):129-135
pubmed: 28848183